Ronak Miladi

Ronak Miladi

Auto-generated profile, based on publicly available information

Ronak Miladi

Department of Infectious Disease, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
AGAzadeh Goodarzi
Azadeh Goodarzi
SESeyed Naser Emadi
Seyed Naser Emadi
RMRonak Miladi
Ronak Miladi
SSSafoura Shakoei
Safoura Shakoei
PHParvaneh Hatami
Parvaneh Hatami
Dermatological disorders are among the most prevalent manifestations of HIV infection/acquired immunodeficiency syndrome (AIDS). In this review, we aimed to characterize the various dermatologic presentations among HIV-infected patients with a detailed categorization of the mucocutaneous signs and symptoms, their etiopathogenic factors, and clinical management. In fact, cutaneous manifestations of HIV are quite various, ranging from AIDS-specific skin eruptions (xerosis, pruritic papular eruptions, eosinophilic folliculitis, and acne), opportunistic infections (herpes simplex, molluscum contagiosum, cutaneous leishmaniasis, bacillary angiomatosis, disseminated histoplasmosis, disseminated cryptococcosis, and zoster) to AIDS-related malignancies (Kaposi’s sarcoma, lymphoma, and nonmelanoma skin cancers) and antiretroviral therapy (ART)-associated drug eruptions. We tried to classify HIV-related cutaneous presentations which can help clinicians for a better understanding of the various specific and nonspecific features of AIDS-associated cutaneous manifestations and management of the condition.

2 February 2022 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
ABArefeh Babazadeh
Arefeh Babazadeh
RMRonak Miladi
Ronak Miladi
MBMohammad Barary
Mohammad Barary
MSMaria Shirvani
Maria Shirvani
Soheil EbrahimpourSoheil Ebrahimpour
Soheil Ebrahimpour
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
Coronavirus disease 2019 (COVID‐19) vaccines significantly impacted world health and well‐being. However, various adverse events have been observed following severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination. Cutaneous reactions have been prevalent following many vaccines, including COVID‐19 vaccines. Here, we present a case of new‐onset lichen planus in a patient who received the COVID‐19 vaccine at the same time as being infected with SARS‐CoV‐2. A 52‐year‐old woman presented to the clinic with extensive pruritic skin lesions. The eruptions had appeared a week after her second dose of the Sinopharm COVID‐19 vaccine. She mentioned a history of SARS‐CoV‐2 infection approximately 10 days following the first dose of her vaccine, causing a 1‐month delay in getting the second dose. Her past medical history was not significant. On examination, erythematous and squamous papules were demonstrated predominantly on the extremities, including inguinal and axillary folds. Moreover, desquamation of the lips was visible, and buccal lesions were also found. After consultation with a dermatologist, a skin biopsy was indicated for the patient, but she refused to undergo the procedure. Therefore, considering the typical appearance of the eruptions, lichen planus was suspected, for which she was treated with oral antihistamines and topical corticosteroids.

7 October 2021 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
PDF file
RMRonak Miladi
Ronak Miladi
AJAlireza Janbakhsh
Alireza Janbakhsh
ABArefeh Babazadeh
Arefeh Babazadeh
ZAZeinab Aryanian
Zeinab Aryanian
Soheil EbrahimpourSoheil Ebrahimpour
Soheil Ebrahimpour
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
Introduction: The various cutaneous manifestations have lately appeared in the setting of COVID‐19. Psoriasis flare‐ups have been reported during a COVID‐19 infection.Case presentation: We present a case of a 32‐year‐old woman with COVID‐19 who presented with generalized pustular psoriasis. She received oral prednisolone, hydroxyzine, and topical clobetasol. The patient received follow‐up two weeks later and found that her lesions were favorably desquamating.Methods: The PubMed, SCOPUS, and ISI Web of Science databases were thoroughly searched for English studies reporting psoriasis flare‐ups following SARS‐CoV‐2 infection. Ten case reports/series were included after screening.Conclusions: Our case report brings awareness to clinicians for the possible cutaneous manifestation of COVID‐19, which should be considered part of the differential diagnoses.

19 December 2021 in Journal of Kermanshah University of Medical Sciences
Verified
Journal Article
Open access
PDF file
MZMohammad Hossein Zamanian
Mohammad Hossein Zamanian
MSMarya Shirvani
Marya Shirvani
AJAlireza Janbakhsh
Alireza Janbakhsh
BSBabak Sayad
Babak Sayad
SVSiavash Vaziri
Siavash Vaziri
MTMitra Tarlan
Mitra Tarlan
Background: Staphylococcus aureus is an opportunistic pathogen, which often causes asymptomatic diseases. This bacterium could cause several disorders, ranging from skin infections to life-threatening diseases. S. aureus could also develop resistance to a wide range of antibiotics. Objectives: The present study aimed to investigate the prevalence and pattern of antibiotic resistance in isolated S. aureus in Imam Reza Hospital of Kermanshah, Iran. Methods: This descriptive cross-sectional study was conducted on 2,228 patients with a positive S. aureus culture who were admitted to Imam Reza Hospital during 2016 - 2018. In accordance with the CLSI protocol, bacterial isolates were separated using laboratory tests, and antibiotic susceptibility was assessed using the standard disk-diffusion method. Data analysis was performed in SPSS version 24. Results: Most of the S. aureus-positive cases were isolated from the emergency ward (43.7%), blood samples (40.1%), and urine samples (23.9%). The highest antibiotic resistance was observed against erythromycin, penicillin G, ofloxacin, cefoxitin, clindamycin, and piperacillin. With 93.3% and 81.8% sensitivity, vancomycin and teicoplanin were respectively the most effective antibiotics against S. aureus. Conclusions: According to the results, the prevalence of resistant S. aureus strains could be due to the long-term hospitalization of patients and the overuse of antibiotics in infection treatment. Therefore, proper monitoring and development of effective infection control methods are essential in these healthcare settings.

12 March 2021 in Journal of Kermanshah University of Medical Sciences
Verified
Journal Article
Open access
PDF file
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
RMRonak Miladi
Ronak Miladi
AJAlireza Janbakhsh
Alireza Janbakhsh
FMFeizollah Mansouri
Feizollah Mansouri
BSBabak Sayad
Babak Sayad
SKSedigheh Khazaei
Sedigheh Khazaei
Background: Antibiotic resistance is spreading worldwide against the Gram-negative bacteria that cause nosocomial infections. Objectives: The present study aimed to determine the antibiotic resistance pattern of Enterobacter isolated from the blood, urine, wound, and sputum samples of the patients referring to Imam Reza Hospital in Kermanshah, Iran. Methods: This descriptive, cross-sectional study was conducted on 649 patients with positive Enterobacter cultures at Imam Reza Hospital during 2016 - 2018. The isolates were obtained using laboratory tests based on the CLSI protocol. In addition, the standard disc-diffusion method was used to assess antibiotic susceptibility. Data analysis was performed in SPSS version 20. Results: Most cases of positive Enterobacteriaceae were isolated from the patients admitted to the intensive care unit (35.6%) and emergency ward (21.9%), as well as the urine (51.6%) and sputum samples (20.5%), respectively. Levofloxacin, ciprofloxacin, and imipenem were the most effective antibiotics against Enterobacter with the susceptibility of 56.7%, 54.8%, and 53.3%, respectively. Conclusions: According to the results, the antibiotic resistance of Enterobacter to ampicillin and ceftriaxone was high, and these antibiotics must be used correctly and reasonably. Furthermore, more epidemiological studies are required in Iran to provide national programs for preventing the spread of antibiotic resistance.

8 July 2023 in Zahedan Journal of Research in Medical Sciences
Verified
Journal Article
Open access
PDF file
MZMohammad Hossein Zamanian
Mohammad Hossein Zamanian
RNRoghayeh Nouri
Roghayeh Nouri
MSMaria Shirvani
Maria Shirvani
ZMZeinab Mohseniafshar
Zeinab Mohseniafshar
RMRonak Miladi
Ronak Miladi
SYSara Yavari
Sara Yavari
Background: Crimean-Congo hemorrhagic fever (CCHF) is a contagious viral disease that can be transmitted through various means, including tick bites, contact with infected blood and animal tissues in slaughterhouses, and healthcare-related infections. Methods: In this study, we examined the incidence of CCHF and analyzed the demographic and clinical data of 130 patients diagnosed with CCHF in Kermanshah, a city located in western Iran, over a period of 15 years (2006 - 2020). Results: During the study, 19 cases tested positive, 66 were verisimilar, and the remaining cases (31.54%) were considered suspected. Among the positive cases, 15 patients recovered, and four died. Of those infected, 63.16% were males residing in rural areas. Additionally, 78.95% of the infected individuals had contact with domestic livestock, 26.31% had a history of contact with ticks, and 10.53% had contact with raw meat or raw liver. Furthermore, 5.26% had a history of contact with a CCHF patient. Conclusions: The highest prevalence of CCHF was observed among men aged 15 to 30 who lived in rural areas. According to the annual reports of people suffering from CCHF, health authorities should prioritize this disease in their public health programs. Since individuals who come into direct contact with livestock and livestock products are at a high risk of contracting diseases, it is important to educate them.